Porton Advanced │ Cell & Gene Therapy CDMO/CRO jobs and careers
Cranbury, NJ, United States
About Porton Advanced │ Cell & Gene Therapy CDMO/CRO
Porton Advanced is a Cell and Gene Therapy (CGT) CDMO/CRO. We provide end-to-end research grade, process development (PD), analytical development (AD), GMP manufacturing, and testing services of AAV, Lentivirus, mRNA, and plasmid to meet clients’ therapeutic product needs at pre-clinical, clinical, and commercial stages. Our dedicated process and analytical development teams have established robust platform-based USP/DSP and GMP manufacturing capability and capacity, as well as proprietary technologies to further empower our clients’ successes. Our services include gene and cell engineering discovery research and technology licensing, process development and analytical development, testing, drug substances (DS) and drug products (DP), and cGMP manufacturing across plasmids, cell therapy, gene therapy, virotherapy, and mRNA-based therapeutic platforms. Contact us Business inquiry and collaboration Email: info@portonadvanced.com Visit our website to find out how Porton Advanced help sponsors to advance their programs.
- Founded
- 2018
- Employees
- 350
- Total funding
- $141.3M
- Headquarters
- Cranbury
Leadership
The top of Porton Advanced │ Cell & Gene Therapy CDMO/CRO's org chart, with how many people report into each leader.
Nianfeng Ju
Chairman & CEO
9 reports
Qingzhou Ji
Assistant Vp, Technical Platform
4 reports
Shelley Hl Wu
Head Of Business Development/ Commercial Team
3 reports
Jobs at Porton Advanced │ Cell & Gene Therapy CDMO/CRO
No open positions right now. Explore more companies on TheJobsMap.